An update on the current status and future prospects of erectile dysfunction following radical prostatectomy

Background Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Prostate 2022-09, Vol.82 (12), p.1135-1161
Hauptverfasser: Asker, Heba, Yilmaz‐Oral, Didem, Oztekin, Cetin Volkan, Gur, Serap
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1161
container_issue 12
container_start_page 1135
container_title The Prostate
container_volume 82
creator Asker, Heba
Yilmaz‐Oral, Didem
Oztekin, Cetin Volkan
Gur, Serap
description Background Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies. Objective This systematic review aims to summarize the current treatments for post‐RP‐ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research. Method Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database. Results Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies. Conclusion This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low‐intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes.
doi_str_mv 10.1002/pros.24366
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2665562960</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2693571096</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3576-9381a01345cac9bca481e4503808164c2507d11bafaec24b4ec5f15d402c05f23</originalsourceid><addsrcrecordid>eNp9kUlPwzAQhS0EgrJc-AHIEheElDJe0xyrik1CArGcI9exIShNih2r6r9nusCBA6eZwzdv5r0h5JTBkAHwq3no4pBLofUOGTAo8gxAql0yAJ5DJpnID8hhjJ8AiAPfJwdCqbwAJQakGbc0zSvTO9q1tP9w1KYQXNvT2Js-RWraivrUp-Doas_c2T7SzlMXsKsbR6tl9KnFHud91zTdom7faTBVbU2znkEhZLvZ8pjsedNEd7KtR-Tt5vp1cpc9PN7eT8YPmRUq11khRswAE1JZY4upNXLEnFQgRjBiWlquIK8YmxpvnOVyKp1VnqlKAregPBdH5GKji9u_kot9OaujdU1jWtelWHKtldK80IDo-R_0s0uhxeuQKvAczFMjdbmhLNqJwflyHuqZCcuSQbn6QbnyWa5_gPDZVjJNZ676RX9CR4BtgAXmt_xHqnx6fnzZiH4DSWmSyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2693571096</pqid></control><display><type>article</type><title>An update on the current status and future prospects of erectile dysfunction following radical prostatectomy</title><source>Wiley Online Library All Journals</source><creator>Asker, Heba ; Yilmaz‐Oral, Didem ; Oztekin, Cetin Volkan ; Gur, Serap</creator><creatorcontrib>Asker, Heba ; Yilmaz‐Oral, Didem ; Oztekin, Cetin Volkan ; Gur, Serap</creatorcontrib><description>Background Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies. Objective This systematic review aims to summarize the current treatments for post‐RP‐ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research. Method Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database. Results Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies. Conclusion This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low‐intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes.</description><identifier>ISSN: 0270-4137</identifier><identifier>EISSN: 1097-0045</identifier><identifier>DOI: 10.1002/pros.24366</identifier><identifier>PMID: 35579053</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Cancer surgery ; cavernous nerve injury ; Cell therapy ; Clinical trials ; Erectile dysfunction ; Gene therapy ; Growth factors ; Immunophilins ; Penis ; Phosphodiesterase ; phosphodiesterase type 5 inhibitors ; Prostate cancer ; Prostatectomy ; radical prostatectomy ; Regeneration ; Rehabilitation ; stem cell therapy ; Stem cells ; Urological surgery</subject><ispartof>The Prostate, 2022-09, Vol.82 (12), p.1135-1161</ispartof><rights>2022 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3576-9381a01345cac9bca481e4503808164c2507d11bafaec24b4ec5f15d402c05f23</citedby><cites>FETCH-LOGICAL-c3576-9381a01345cac9bca481e4503808164c2507d11bafaec24b4ec5f15d402c05f23</cites><orcidid>0000-0003-2057-3781 ; 0000-0002-9515-0698 ; 0000-0003-2082-2135 ; 0000-0002-1730-7282</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fpros.24366$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fpros.24366$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35579053$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asker, Heba</creatorcontrib><creatorcontrib>Yilmaz‐Oral, Didem</creatorcontrib><creatorcontrib>Oztekin, Cetin Volkan</creatorcontrib><creatorcontrib>Gur, Serap</creatorcontrib><title>An update on the current status and future prospects of erectile dysfunction following radical prostatectomy</title><title>The Prostate</title><addtitle>Prostate</addtitle><description>Background Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies. Objective This systematic review aims to summarize the current treatments for post‐RP‐ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research. Method Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database. Results Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies. Conclusion This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low‐intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes.</description><subject>Cancer surgery</subject><subject>cavernous nerve injury</subject><subject>Cell therapy</subject><subject>Clinical trials</subject><subject>Erectile dysfunction</subject><subject>Gene therapy</subject><subject>Growth factors</subject><subject>Immunophilins</subject><subject>Penis</subject><subject>Phosphodiesterase</subject><subject>phosphodiesterase type 5 inhibitors</subject><subject>Prostate cancer</subject><subject>Prostatectomy</subject><subject>radical prostatectomy</subject><subject>Regeneration</subject><subject>Rehabilitation</subject><subject>stem cell therapy</subject><subject>Stem cells</subject><subject>Urological surgery</subject><issn>0270-4137</issn><issn>1097-0045</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kUlPwzAQhS0EgrJc-AHIEheElDJe0xyrik1CArGcI9exIShNih2r6r9nusCBA6eZwzdv5r0h5JTBkAHwq3no4pBLofUOGTAo8gxAql0yAJ5DJpnID8hhjJ8AiAPfJwdCqbwAJQakGbc0zSvTO9q1tP9w1KYQXNvT2Js-RWraivrUp-Doas_c2T7SzlMXsKsbR6tl9KnFHud91zTdom7faTBVbU2znkEhZLvZ8pjsedNEd7KtR-Tt5vp1cpc9PN7eT8YPmRUq11khRswAE1JZY4upNXLEnFQgRjBiWlquIK8YmxpvnOVyKp1VnqlKAregPBdH5GKji9u_kot9OaujdU1jWtelWHKtldK80IDo-R_0s0uhxeuQKvAczFMjdbmhLNqJwflyHuqZCcuSQbn6QbnyWa5_gPDZVjJNZ676RX9CR4BtgAXmt_xHqnx6fnzZiH4DSWmSyw</recordid><startdate>20220901</startdate><enddate>20220901</enddate><creator>Asker, Heba</creator><creator>Yilmaz‐Oral, Didem</creator><creator>Oztekin, Cetin Volkan</creator><creator>Gur, Serap</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2057-3781</orcidid><orcidid>https://orcid.org/0000-0002-9515-0698</orcidid><orcidid>https://orcid.org/0000-0003-2082-2135</orcidid><orcidid>https://orcid.org/0000-0002-1730-7282</orcidid></search><sort><creationdate>20220901</creationdate><title>An update on the current status and future prospects of erectile dysfunction following radical prostatectomy</title><author>Asker, Heba ; Yilmaz‐Oral, Didem ; Oztekin, Cetin Volkan ; Gur, Serap</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3576-9381a01345cac9bca481e4503808164c2507d11bafaec24b4ec5f15d402c05f23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Cancer surgery</topic><topic>cavernous nerve injury</topic><topic>Cell therapy</topic><topic>Clinical trials</topic><topic>Erectile dysfunction</topic><topic>Gene therapy</topic><topic>Growth factors</topic><topic>Immunophilins</topic><topic>Penis</topic><topic>Phosphodiesterase</topic><topic>phosphodiesterase type 5 inhibitors</topic><topic>Prostate cancer</topic><topic>Prostatectomy</topic><topic>radical prostatectomy</topic><topic>Regeneration</topic><topic>Rehabilitation</topic><topic>stem cell therapy</topic><topic>Stem cells</topic><topic>Urological surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asker, Heba</creatorcontrib><creatorcontrib>Yilmaz‐Oral, Didem</creatorcontrib><creatorcontrib>Oztekin, Cetin Volkan</creatorcontrib><creatorcontrib>Gur, Serap</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Prostate</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asker, Heba</au><au>Yilmaz‐Oral, Didem</au><au>Oztekin, Cetin Volkan</au><au>Gur, Serap</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An update on the current status and future prospects of erectile dysfunction following radical prostatectomy</atitle><jtitle>The Prostate</jtitle><addtitle>Prostate</addtitle><date>2022-09-01</date><risdate>2022</risdate><volume>82</volume><issue>12</issue><spage>1135</spage><epage>1161</epage><pages>1135-1161</pages><issn>0270-4137</issn><eissn>1097-0045</eissn><abstract>Background Radical prostatectomy (RP) and radiation treatment are standard options for localized prostate cancer. Even though nerve‐sparing techniques have been increasingly utilized in RP, erectile dysfunction (ED) due to neuropraxia remains a frequent complication. Erectile function recovery rates after RP remain unsatisfactory, and many men still suffer despite the availability of various therapies. Objective This systematic review aims to summarize the current treatments for post‐RP‐ED, assess the underlying pathological mechanisms, and emphasize promising therapeutic strategies based on the evidence from basic research. Method Evaluation and review of articles on the relevant topic published between 2010 and 2021, which are indexed and listed in the PubMed database. Results Phosphodiesterase type 5 inhibitors, intracavernosal and intraurethral injections, vacuum erection devices, pelvic muscle training, and surgical procedures are utilized for penile rehabilitation. Clinical trials evaluating the efficacy of erectogenic drugs in this setting are conflicting and far from being conclusive. The use of androgen deprivation therapy in certain scenarios after RP further exacerbates the already problematic situation and emphasizes the need for effective treatment strategies. Conclusion This article is a detailed overview focusing on the pathophysiology and mechanism of the nerve injury developed during RP and a compilation of various strategies to induce cavernous nerve regeneration to improve erectile function (EF). These strategies include stem cell therapy, gene therapy, growth factors, low‐intensity extracorporeal shockwave therapy, immunophilins, and various pharmacological approaches that have induced improvements in EF in experimental models of cavernous nerve injury. Many of the mentioned strategies can improve EF following RP if transformed into clinically applicable safe, and effective techniques with reproducible outcomes.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>35579053</pmid><doi>10.1002/pros.24366</doi><tpages>27</tpages><orcidid>https://orcid.org/0000-0003-2057-3781</orcidid><orcidid>https://orcid.org/0000-0002-9515-0698</orcidid><orcidid>https://orcid.org/0000-0003-2082-2135</orcidid><orcidid>https://orcid.org/0000-0002-1730-7282</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0270-4137
ispartof The Prostate, 2022-09, Vol.82 (12), p.1135-1161
issn 0270-4137
1097-0045
language eng
recordid cdi_proquest_miscellaneous_2665562960
source Wiley Online Library All Journals
subjects Cancer surgery
cavernous nerve injury
Cell therapy
Clinical trials
Erectile dysfunction
Gene therapy
Growth factors
Immunophilins
Penis
Phosphodiesterase
phosphodiesterase type 5 inhibitors
Prostate cancer
Prostatectomy
radical prostatectomy
Regeneration
Rehabilitation
stem cell therapy
Stem cells
Urological surgery
title An update on the current status and future prospects of erectile dysfunction following radical prostatectomy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A19%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20update%20on%20the%20current%20status%20and%20future%20prospects%20of%20erectile%20dysfunction%20following%20radical%20prostatectomy&rft.jtitle=The%20Prostate&rft.au=Asker,%20Heba&rft.date=2022-09-01&rft.volume=82&rft.issue=12&rft.spage=1135&rft.epage=1161&rft.pages=1135-1161&rft.issn=0270-4137&rft.eissn=1097-0045&rft_id=info:doi/10.1002/pros.24366&rft_dat=%3Cproquest_cross%3E2693571096%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2693571096&rft_id=info:pmid/35579053&rfr_iscdi=true